Faculty

Institution

Unit

Venue

Gary Gudelsky

Professor - Emeritus

University of Cincinnati

Affiliations

College of Pharmacy

Pharmaceutical Sciences

Gary Gudelsky is currently serving as a College Of Pharmacy Professor - Emeritus at University of Cincinnati.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Gary Gudelsky

University of Cincinnati

Professor - Emeritus

You can click a keyword to filter the displayed items

pharmacology neuroscience neuropharmacology neurology endocrinology dopamine neurochemistry neuropsychopharmacology neurophysiology physiology pharmacotherapy psychopharmacology neurotransmission central nervous system behavioral neuroscience pharmacological research cancer treatment mammalian biology pharmacokinetics psychoneuroendocrinology receptors toxicology brain tumor research brain science neuroanatomy medicinal research brain function clinical neuroscience neurotransmitters anti-cancer agents biological psychiatry tuberoinfundibular dopamine neurons rat brain clinical pharmacology experimental pharmacology neuroinflammation tumor targeting endocrine research pituitary gland prolactin secretion prefrontal cortex animal physiology cellular neurobiology extracellular concentration dopamine turnover rat prefrontal cortex cancer care drug treatment neural science molecular neurobiology hyperthermia brain stimulation rat prolactin secretion anterior pituitary gland animal cognition avian medicine cell death release mechanism translational pharmacology mammalian physiology drug targeting median eminence tuberoinfundibular neurons hydroxyl radicals learning disabilities liver physiology experimental medicine developmental endocrinology treatment effects developmental toxicology experimental toxicology neurotoxic regimen dopaminergic control hypophysial portal vasculature path integration learning specific learning disorders molecular endocrinology molecular pharmacology applied pharmacology addiction substance misuse

Notable Scholarly Works

Notable Federal Grants

Collaborators

Preclinical Evaluation of the Efficacy of a Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination With Letrozole Against Patient-Derived Glioblastoma Cells. Molecular Cancer Therapeutics (2025)

radiation oncologytumor biologyanti-cancer agentsgliomasbrain tumor researchmolecular cancerpreclinical evaluationcancer growthpharmacologytherapeutic targetspharmacotherapycancer treatmentoncologyneuro-oncology

Psychedelics as Pharmacotherapeutics for Substance Use Disorders: A Scoping Review on Clinical Trials and Perspectives on Underlying Neurobiology. British Journal of Pharmacology (2025)

substance use disorderspsychiatryneuropharmacologybiological psychiatryaddiction medicineneuropsychopharmacologyneuroscienceclinical trialstranslational psychiatryaddictionpharmacologypsychopharmacologypsychopathologypsychoactive drugs

Abstract 2119: Translational Research to Facilitate Development of Novel Therapeutic Combinations of Letrozole for the Treatment of Glioblastoma. Cancer Research (2024)

Aniruddha Sunil KarveBhavesh Babulal GabaniSidharth Nitin GadgilShravani Parag KulkarniGary A. GudelskyPankaj B. Desai

drug developmentpharmacologynovel therapeutic combinationstranslational researchnovel therapiescancer researchcancer treatmentpharmacotherapymedicinal researchcancer carecancer biologyneurologybrain tumor researchtreatment developmentmedicineclinical researchenzyme inhibitiononcologyneuro-oncology

A Review of Approaches to Potentiate the Activity of Temozolomide Against Glioblastoma to Overcome Resistance. International Journal of Molecular Sciences (2024)

Aniruddha S. KarveJanki M. DesaiSidharth N. GadgilNimita DaveTrisha M. Wise-DraperGary A. GudelskyTimothy N. PhoenixBiplab DasGuptaLalanthica YogendranSoma SenguptaDavid R. PlasPankaj B. Desai

drug safetytumor targetingtumor biologyneuropharmacologydrug targetinganti-cancer agentsmedicinal researchneurosciencebrain tumor researchmolecular sciencedrug resistancepharmacologymedicinepharmacotherapycancer treatmentoncologyneuro-oncology

Transcriptomic Dynamics Governing Serotonergic Dysregulation in the Dorsal Raphe Nucleus Following Mild Traumatic Brain Injury. Experimental Neurology (2024)

Christopher J. O'ConnellEvan L. ReederJacob A. HymoreRyan S. BrownGabrielle A. NotorgiacomoSean M. CollinsGary A. GudelskyMatthew J. Robson

neurologyserotonergic dysregulationtranscriptomic dynamicsneurochemistrysystems neuroscienceneuropharmacologycellular neurobiologycognitive neuroscienceneuroscienceneurophysiologyneurodynamicstranscription regulationpharmacologyclinical neurosciencemolecular neuroscience

Data From Preclinical Pharmacological Evaluation of Letrozole as a Novel Treatment for Gliomas. (2023)

Nimita DaveLionel M.L. ChowGary A. GudelskyKathleen LaSanceXiaoyang QiPankaj B. Desai

novel treatmentneurologyradiation oncologypreclinical pharmacological evaluationpharmacologypharmacotherapycancer treatmentoncologyneuro-oncology

Supplementary Figure 1 and Supplementary Table 1 From Preclinical Pharmacological Evaluation of Letrozole as a Novel Treatment for Gliomas. (2023)

Nimita DaveLionel M.L. ChowGary A. GudelskyKathleen LaSanceXiaoyang QiPankaj B. Desai

novel treatmentradiation oncologypreclinical pharmacological evaluationmedicinepharmacologycancer treatmentoncologyneuro-oncology

Altered Serotonin 2A (5-Ht2A) Receptor Signaling Underlies Mild Tbi-Elicited Deficits in Social Dominance. Frontiers in Pharmacology (2022)

Sean M. CollinsChristopher J. O’ConnellEvan L. ReederSophia V. NormanKainat LunganiPoornima GopalanGary A. GudelskyMatthew J. Robson

neurologyneuropharmacologybiological psychiatrymedicinal researchneuropsychopharmacologyschizophrenianeuroscienceexperimental pharmacologypharmacokineticssocial dominancepharmacologytranslational pharmacologymolecular pharmacologydrug discoverypharmacotherapypharmacological researchtbi-elicited deficitsclinical pharmacology

Altered Serotonin 2A (5-Ht 2A ) Receptor Signaling Underlies Mild Tbi-Elicited. Frontiers in Pharmacology (2022)

neuropharmacologyneuropsychopharmacologyneurosciencereceptor (biochemistry)altered serotonin 2apharmacologysignal transductionreceptorsneurotransmitters

Brain Pharmacokinetics and Metabolism of the Amp-Activated Protein Kinase Selective Inhibitor Sbi-0206965, an Investigational Agent for the Treatment of Glioblastoma. Investigational New Drugs (2022)

Janki M. DesaiAniruddha S. KarveGary A. GudelskyMruniya V. GawaliWilliam SeibelLarry SallansBiplab DasGuptaPankaj B. Desai

neurologyneuropharmacologyinvestigational agentclinical investigationbrain tumor researchmedicinepharmacologydrug metabolismclinical researchcancer treatmentclinical neurosciencebrain pharmacokineticsneuro-oncology

1
2
3
4
5
20
10 / page

Gary Gudelsky

Professor - Emeritus

University of Cincinnati

Affiliations

College of Pharmacy

Pharmaceutical Sciences

Gary Gudelsky is currently serving as a College Of Pharmacy Professor - Emeritus at University of Cincinnati.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Gary Gudelsky

University of Cincinnati

Professor - Emeritus

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Psychedelics as Pharmacotherapeutics for Substance Use Disorders: A Scoping Review on Clinical Trials and Perspectives on Underlying Neurobiology. British Journal of Pharmacology (2025)

Abstract 2119: Translational Research to Facilitate Development of Novel Therapeutic Combinations of Letrozole for the Treatment of Glioblastoma. Cancer Research (2024)

Aniruddha Sunil KarveBhavesh Babulal GabaniSidharth Nitin GadgilShravani Parag KulkarniGary A. GudelskyPankaj B. Desai

A Review of Approaches to Potentiate the Activity of Temozolomide Against Glioblastoma to Overcome Resistance. International Journal of Molecular Sciences (2024)

Aniruddha S. KarveJanki M. DesaiSidharth N. GadgilNimita DaveTrisha M. Wise-DraperGary A. GudelskyTimothy N. PhoenixBiplab DasGuptaLalanthica YogendranSoma SenguptaDavid R. PlasPankaj B. Desai

Transcriptomic Dynamics Governing Serotonergic Dysregulation in the Dorsal Raphe Nucleus Following Mild Traumatic Brain Injury. Experimental Neurology (2024)

Christopher J. O'ConnellEvan L. ReederJacob A. HymoreRyan S. BrownGabrielle A. NotorgiacomoSean M. CollinsGary A. GudelskyMatthew J. Robson

Data From Preclinical Pharmacological Evaluation of Letrozole as a Novel Treatment for Gliomas. (2023)

Nimita DaveLionel M.L. ChowGary A. GudelskyKathleen LaSanceXiaoyang QiPankaj B. Desai

novel treatmentneurologyradiation oncologypreclinical pharmacological evaluationpharmacologypharmacotherapycancer treatmentoncologyneuro-oncology

Supplementary Figure 1 and Supplementary Table 1 From Preclinical Pharmacological Evaluation of Letrozole as a Novel Treatment for Gliomas. (2023)

Nimita DaveLionel M.L. ChowGary A. GudelskyKathleen LaSanceXiaoyang QiPankaj B. Desai

novel treatmentradiation oncologypreclinical pharmacological evaluationmedicinepharmacologycancer treatmentoncologyneuro-oncology

Altered Serotonin 2A (5-Ht2A) Receptor Signaling Underlies Mild Tbi-Elicited Deficits in Social Dominance. Frontiers in Pharmacology (2022)

Sean M. CollinsChristopher J. O’ConnellEvan L. ReederSophia V. NormanKainat LunganiPoornima GopalanGary A. GudelskyMatthew J. Robson

Altered Serotonin 2A (5-Ht 2A ) Receptor Signaling Underlies Mild Tbi-Elicited. Frontiers in Pharmacology (2022)

neuropharmacologyneuropsychopharmacologyneurosciencereceptor (biochemistry)altered serotonin 2apharmacologysignal transductionreceptorsneurotransmitters

Janki M. DesaiAniruddha S. KarveGary A. GudelskyMruniya V. GawaliWilliam SeibelLarry SallansBiplab DasGuptaPankaj B. Desai

1
2
3
4
5
20
10 / page

Similar Faculty Members

David Nichols

Institution

University of North Carolina at Chapel Hill

pharmacology

neuroscience

Jean C. Shih

Institution

University of Southern California

psychiatry

neurogenetics

Michael Bardo

Institution

University of Kentucky

pharmacology

neuroscience

Charles Chavkin

Institution

University of Washington

pain research

neuropsychopharmacology

Todd Vanderah, PhD

Institution

University of Arizona

acute pain

chronic pain

Efrain C Azmitia

Institution

New York University

neuronal serotonin

neurodevelopmental disorder

Eugenia V. Gurevich

Institution

Vanderbilt University

neuroscience

plastic changes

Gregg E. Homanics

Institution

University of Pittsburgh

pharmacological research

neuropsychopharmacology

Greg Gerhardt

Institution

University of Kentucky

degenerative disease

degenerative pathology

Glen R. Hanson

Institution

University of Utah

neuropsychopharmacology

pharmacology

Similar Faculty Members

David Nichols

Institution

University of North Carolina at Chapel Hill

pharmacology

neuroscience

Jean C. Shih

Institution

University of Southern California

psychiatry

neurogenetics

Michael Bardo

Institution

University of Kentucky

pharmacology

neuroscience

Charles Chavkin

Institution

University of Washington

pain research

neuropsychopharmacology

Todd Vanderah, PhD

Institution

University of Arizona

acute pain

chronic pain

Efrain C Azmitia

Institution

New York University

neuronal serotonin

neurodevelopmental disorder

Eugenia V. Gurevich

Institution

Vanderbilt University

neuroscience

plastic changes

Gregg E. Homanics

Institution

University of Pittsburgh

pharmacological research

neuropsychopharmacology

Greg Gerhardt

Institution

University of Kentucky

degenerative disease

degenerative pathology

Glen R. Hanson

Institution

University of Utah

neuropsychopharmacology

pharmacology